Travelers with Covaxin can enter the United States after the vaccine obtains a WHO EUL

This post contains affiliate links. Read the full disclosure here.

As an Amazon Associate I earn from qualifying purchases.

Foreign tourists fully vaccinated against COVID-19 with Covaxin have been given the green light to enter the United States from November 8.

The Centers for Disease Control said the vaccine would be added to its list of vaccines acceptable to foreign travelers on Wednesday after the World Health Organization granted Covaxin’s emergency use list.

“The CDC travel guide applies to vaccines approved or authorized by the FDA and the WHO emergency use list and includes all new vaccines that may be added to any of these lists in the over time, “CDC spokeswoman Kristen Nordlund told USA TODAY.

The last-minute addition comes less than a week before the United States launches its new travel system, which allows entry to foreign travelers who have received a vaccine that has been approved for use. emergency by the US Food and Drug Administration or the WHO.

► From vaccines to tests:What travelers need to know before the new U.S. travel system on November 8th

► “You feel lonely and left out”:These fully vaccinated travelers want to visit the US. They may not be allowed to enter.

The new U.S. travel rules will also accept fully vaccinated travelers with Pfizer-BioNTech, Johnson & Johnson, Moderna, Oxford-AstraZeneca, Covishield, Sinopharm and Sinovac.

There are some exceptions to the vaccination requirement, including travelers under the age of 18. Travelers should also get a coronavirus test before arriving.

Prior to Wednesday’s announcement, the CDC had planned to allow travelers vaccinated with Covaxin to enter the U.S. only if they had been participating in a phase three trial of the vaccine.

Covaxin, developed by Indian biotechnology company Bharat Biotech in collaboration with the Indian Medical Research Council, has an 78% efficacy rate against COVID-19 and is “extremely suitable” for revenue countries. low and medium because it is easy to store. , According to the WHO.

The vaccine is popular in India and Bharat Biotech has said it has received emergency use authorization in several other countries such as Mexico, Philippines, Iran and Paraguay.

Follow USA TODAY journalist Bailey Schulz on Twitter: @bailey_schulz.

Amazon and the Amazon logo are trademarks of, Inc, or its affiliates.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.